v3.26.1
Stockholders’ Equity (Deficit)
1 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Stockholders’ Equity (Deficit)

Note 10 — Stockholders’ Equity (Deficit)

 

During the fiscal year ended November 30, 2022, and through May 15, 2023, the Company was authorized to issue 75,000,000 shares of common stock with a par value of $0.001.

 

On May 16, 2023, the Company filed an amendment to the Articles of Incorporation with the State of Nevada to increase the total number of shares authorized to 1,000,100,000, consisting of 1,000,000,000 shares of common stock with a par value of $0.001 and 100,000 shares of Series A Super-Voting Preferred stock with a par value of $0.001. The Series A Super-Voting Preferred stock vote on the basis of 10,000 votes per share. The common stock vote on the basis of 1 vote per share.

 

Shares Issued for Cash

 

During the transition period ended December 31, 2025, the Company issued 2,333,855 shares of common stock for cash received of $257,155.

 

Shares Issued for Services

 

During the fiscal year ended November 30, 2024, the Company issued 10,000,000 shares of common stock issued for future services valued at $1,000,000. These shares were recorded as deferred stock-based compensation and the value of the shares is being amortized over three years. The value of the deferred stock-based compensation is an offset to additional paid-in capital. During the transition period ended December 31, 2025, the Company recorded $27,778 as consulting services and deducted that amount from deferred stock-based compensation. At the transition period ended December 31, 2025, the deferred stock-based compensation balance was $805,556.

 

Shares to be Issued

 

During the transition period ended December 31, 2025, the Company received $409,778 for 4,837,056 shares of common stock to be issued. At the transition period ended December 31, 2025, the value of these shares was recorded in additional paid in capital These shares were all issued during the subsequent period and are part of the shares issued for cash in the subsequent events footnote.

 

 

Subscription Receivable

 

As of the end of the transition period of December 31, 2025, the Company had $53,785 recorded as subscription receivable for shares issued for which funds have not yet been received. This is accounted as an offset to additional paid-in capital.

 

Convertible Note Payable Conversion

 

During the transition period ended December 31, 2025, the convertible note holder (see Footnote 8) converted $40,000 principal and $8,241 accrued interest into 1,042,090 shares of common stock.